TABLE 2.
Delivery Room and Respiratory Focused Therapies Among Survivors to Discharge
| Therapy | All Infants (N = 22 131) | No BPD (n = 12 192) | Grade 1–2 BPD (n = 9126) | Grade 3 BPD (n = 813) |
|---|---|---|---|---|
| Endotracheal tube ventilation during initial resuscitation | 11 124 (50.3) | 4544 (37.3) | 5923 (65.0) | 657 (81.0) |
| Epinephrine or cardiac compressions during initial resuscitation | 316 (1.4) | 104 (0.9) | 183 (2.0) | 29 (3.6) |
| Invasive ventilation after initial resuscitation | 15 255 (68.9) | 6550 (53.7) | 7892 (86.5) | 813 (100) |
| Surfactant | 15 930 (72.0) | 7321 (60.1) | 7850 (86.1) | 759 (93.5) |
| Inhaled nitric oxide | 1087 (4.9) | 145 (1.2) | 708 (7.8) | 234 (28.9) |
| Systemic corticosteroids for chronic lung disease | 4009 (18.1) | 456 (3.7) | 3033 (33.2) | 520 (64.0) |
| Caffeine | 21 246 (96.1) | 11 502 (94.4) | 8952 (98.2) | 792 (97.4) |
| Intramuscular Vitamin A | 1772 (8.0) | 663 (5.4) | 1013 (11.1) | 96 (11.8) |
Data shown in the table are number of infants (%). All percentage values were calculated among infants with complete data for the described variable. Data shown in the table were missing in <1% of study infants.